Temporal Trends in Biologic Prescriptions for Patient with Inflammatory Bowel Disease: A Retrospective Cohort Study

Temporal Trends in Biologic Prescriptions for Patient with Inflammatory Bowel Disease: A Retrospective Cohort Study

<b>Background:</b> Biologic therapies, such antitumour necrosis factor-alpha agents (infliximab and adalimumab), as well as newer agents (ustekinumab and vedolizumab), all have well-demonstrated safety and efficacy profiles in the management of inflammatory bowel disease (IBD). The choic...

Full description

Saved in:
Bibliographic Details
Main Authors: Sunimal Fernando, Reeham Abu-Rgeef, Shankar Menon, Kenji So, Kannan Venugopal, Sherman Picardo
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Gastroenterology Insights
Subjects:
biologic therapies
biologic therapy sequencing
ulcerative colitis
Crohn’s disease
inflammatory bowel disease
Online Access:https://www.mdpi.com/2036-7422/16/1/4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items